BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Wang J, Gao YS, Xu K, Li XD. Combination of atezolizumab and chidamide to maintain long-term remission in refractory metastatic extranodal natural killer/T-cell lymphoma: A case report. World J Clin Cases 2022; 10(5): 1609-1616 [PMID: 35211600 DOI: 10.12998/wjcc.v10.i5.1609]
URL: https://www.wjgnet.com/2307-8960/full/v10/i5/1609.htm
Number Citing Articles
1
Multiple drugsReactions Weekly 2022; 1906(1): 309 doi: 10.1007/s40278-022-15199-0
2
Shuhui Zhuang, Zhaobo Yang, Zhuangzhuang Cui, Yuanyuan Zhang, Fengyuan Che. Epigenetic alterations and advancement of lymphoma treatmentAnnals of Hematology 2024; 103(5): 1435 doi: 10.1007/s00277-023-05395-z
3
Zheng Yan, Shuna Yao, Zhizhong Wang, Wenping Zhou, Zhihua Yao, Yanyan Liu. Treatment of extranodal NK/T-cell lymphoma: From past to futureFrontiers in Immunology 2023; 14 doi: 10.3389/fimmu.2023.1088685
4
Ajay Major, Pierluigi Porcu, Bradley M. Haverkos. Rational Targets of Therapy in Extranodal NK/T-Cell LymphomaCancers 2023; 15(5): 1366 doi: 10.3390/cancers15051366
5
Jianing Wang, Junbao Xu, Xiaoqing Ma, Qianqian Wang, Zhengchun Liu, Xuecheng Zhang, Yongqiang Wei, Shuai Wang, Chunjing Liang, Peiling Zhai. Epigenetic therapy combined with radiotherapy reshapes tumor immune responseExperimental and Molecular Pathology 2026; 146: 105040 doi: 10.1016/j.yexmp.2026.105040
Write to the Help Desk